Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.

Item

http://www.wikidata.org/entity/Q38871993

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Management of Chronic Obstruct ...... with Cardiovascular Diseases.

@en

type

Item

label

Management of Chronic Obstruct ...... with Cardiovascular Diseases.

@en

prefLabel

Management of Chronic Obstruct ...... with Cardiovascular Diseases.

@en

P1476

Management of Chronic Obstruct ...... with Cardiovascular Diseases.

@en

P2093

Barbara Rinaldi

http://www.w3.org/2001/XMLSchema#string

Clive Page

http://www.w3.org/2001/XMLSchema#string

Giuseppe Rosano

http://www.w3.org/2001/XMLSchema#string

Luigino Calzetta

http://www.w3.org/2001/XMLSchema#string

Maria Gabriella Matera

http://www.w3.org/2001/XMLSchema#string

Mario Cazzola

http://www.w3.org/2001/XMLSchema#string

P2860

Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.

The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists.

A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.

Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials.

Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Tiotropium Respimat inhaler and the risk of death in COPD.

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

P2888

s40265-017-0731-3

P304

721-732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-017-0731-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paola Rogliani

P577

2017-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084038547

http://www.w3.org/2001/XMLSchema#string

P698

28349353

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

cardiovascular disease